Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Study protocol

Psychological distress, chronic conditions and quality of life in elderly hematologic cancer patients: study protocol of a prospective study

Authors: Norbert Köhler, Anja Mehnert, Heide Götze

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Similar to most solid tumors, the incidence of hematologic malignancies has been rising. Although the median age at diagnosis is about 70 years, little is known about psychosocial aspects and comorbid conditions in elderly patients with hematologic cancers. The main objectives of our study are to assess the prevalence of psychological distress, chronic conditions, functional disabilities, and quality of life in both elderly hematologic cancer patients aged ≥70 years and an age-matched comparison sample of the general population.

Methods

We conduct a prospective study with three measuring points (t_1: ≥5 years after first time hematologic cancer diagnosis / relapse; t_2 and t_3 six months and 1 year after t_1). In addition, we use a cross sectional study design to recruit a comparison sample of the general population matched by age and sex. Both samples, patients and the comparison group complete validated questionnaires measuring psychological distress, chronic conditions, functional disabilities, and quality of life as well as health care needs and health care utilization.

Discussion

Our study will provide both a data set offering detailed information about elderly hematologic cancer patients’ physical, psychological and demographic characteristics, and reference data of the elderly general population. Furthermore, the study will provide important information for the development and implementation of psychooncological support offers and survivorship care plans.
Literature
1.
2.
World Health Organization. International statistical classification of diseases and related health problems. 10th ed. Geneva: World Health Organization; 2011.
3.
Sant M, Allemani C, Tereanu C, Angelis RD, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116:3724–34.CrossRefPubMed
4.
Joshi M, Sheikh H, Abbi K, Long S, Sharma K, Tulchinsky M, et al. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies. Ther Adv Hematol. 2012;3:275–90.CrossRefPubMedPubMedCentral
5.
6.
Müller LP, Müller-Tidow C. The indications for allogeneic stem cell transplantation in myeloid malignancies. Dtsch Arztebl Int. 2015;112:262.PubMedPubMedCentral
7.
Wiesel TRW, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, et al. The relationship between age, anxiety, and depression in older adults with cancer. Psychooncology. 2014;24:712–7.CrossRef
8.
Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C, et al. Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer. 2013;21:2853–60.CrossRefPubMed
9.
10.
Given BA, Given CW. The Older Patient. In: Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R, editors. Psycho-Oncology. Oxford: Oxford University Press; 2010. p. 491–6.
11.
Cohen M. Depression, anxiety, and somatic symptoms in older cancer patients: a comparison across age groups. Psychooncology. 2013;23:151–7.CrossRefPubMed
12.
Holtzer-Goor KM, Schaafsma MR, Joosten P, Posthuma EFM, Wittebol S, Huijgens PC, et al. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study. Qual Life Res. 2015;24:2895–906.CrossRefPubMedPubMedCentral
13.
Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica. 2007;92:1596–8.CrossRefPubMed
14.
Efficace F, Cardoni A, Cottone F, Vignetti M, Mandelli F. Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: A systematic review. Leuk Res. 2013;37:206–13.CrossRefPubMed
15.
16.
17.
18.
Trask PC, Blank TO, Jacobsen PB. Future perspectives on the treatment issues associated with cancer and aging. Cancer. 2008;113:3512–8.CrossRefPubMed
19.
Rowe J, Patel S, Mazo-Canola M, Parra A, Goros M, Michalek J, et al. An evaluation of elderly patients (>=70years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011. J Geriatr Oncol. 2014;5:65–70.CrossRefPubMed
20.
Hamilton BK, Rybicki L, Dabney J, McLellan L, Haddad H, Foster L, et al. Quality of life and outcomes in patients >=60 years of age after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014;49:1426–31.CrossRefPubMed
21.
Cannella L, Caocci G, Jacobs M, Vignetti M, Mandelli F, Efficace F. Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned? Crit Rev Oncol Hematol. 2015;96:542–54.CrossRefPubMed
22.
Deschler B, de Witte T, Mertelsmann R, Lübbert M. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. Haematologica. 2006;91:1513–22.PubMed
23.
24.
Korc-Grodzicki B, Boparai MK, Lichtman SM. Prescribing for older patients with cancer. Clin Adv Hematol Oncol. 2014;12:309–18.PubMed
25.
Gheihman G, Zimmermann C, Deckert A, Fitzgerald P, Mischitelle A, Rydall A, et al. Depression and hopelessness in patients with acute leukemia: the psychological impact of an acute and life-threatening disorder. Psychooncology. 2016:979–89.
26.
Tzelepis F, Sanson-Fisher RW, Hall AE, Carey ML, Paul CL, Clinton-McHarg T. The quality of patient-centred care: haematological cancer survivors’ perceptions. Psychooncology. 2014;24:796–803.CrossRefPubMed
27.
Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality of life health outcomes: Initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes. 2005;3:51.CrossRefPubMedPubMedCentral
28.
Bayliss EA, Ellis JL, Steiner JF. Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. J Clin Epidemiol. 2009;62:550–7.CrossRefPubMed
29.
Lachs MSA. Simple Procedure for General Screening for Functional Disability in Elderly Patients. Ann Intern Med. 1990;112:699.CrossRefPubMed
30.
Spitzer RL. Validation and Utility of a Self-report Version of PRIME-MD. The PHQ Primary Care Study. JAMA. 1999;282:1737.CrossRefPubMed
31.
32.
Löwe B, Kroenke K, Herzog W, Gräfe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81:61–6.CrossRefPubMed
33.
Spitzer RL, Kroenke K, Williams JBW, Löwe BA. Brief Measure for Assessing Generalized Anxiety Disorder. Arch Intern Med. 2006;166:1092.CrossRefPubMed
34.
Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998;82:1904–8.CrossRefPubMed
35.
Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. ZPPP. 2006;54:213–23.
36.
Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriat Psychiatry. 1999;14:858–65.CrossRef
37.
Yesavage JA, Sheikh JI. Geriatric Depression Scale (GDS). Clin Gerontol. 1986;5:165–73.CrossRef
38.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
39.
Schumacher J, Klaiberg A, Braehler E. Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Goettingen: Hogrefe; 2003.
40.
Kaufmann A, Schmidt H, Ostheimer C, Ullrich J, Landenberger M, Vordermark D. Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module. Support Care Cancer. 2014;23:1883–92.CrossRefPubMed
41.
Radbruch L, Sabatowski R, Elsner F, Everts J, Mendoza T, Cleeland C. Validation of the German Version of the Brief Fatigue Inventory. J Pain Symptom Manag. 2003;25:449–58.CrossRef
42.
Henrich G, Herschbach P. Questions on Life Satisfaction (FLZM) - A Short Questionnaire for Assessing Subjective Quality of Life. Eur J Psychol Assess. 2000;16:150–9.CrossRef
43.
Arraras JI, Villafranca E, Vega FA de la, Romero P, Rico M, Vila M, et al. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients. Clin Transl Oncol 2009;11:160–164.
44.
Lubben J, Blozik E, Gillmann G, Iliffe S, Kruse W v R, Beck JC, et al. Performance of an Abbreviated Version of the Lubben Social Network Scale Among Three European Community-Dwelling Older Adult Populations. Gerontologist. 2006;46:503–13.CrossRefPubMed
45.
Revenson T, Schiaffino K. Development of a contextual social support measure for use with arthritis populations. Conv Arthritis Health Professionals’ Association. 1990;
46.
Ullrich A, Mehnert A. Psychometrische Evaluation and Validierung einer 8-Item Kurzversion der Skalen zur Sozialen Unterstützung bei Krankheit (SSUK) bei Krebspatienten. Klinische Diagnostik und Evaluation. 2010;3:359–81.
47.
Kliem S, Job A-K, Kröger C, Bodenmann G, Stöbel-Richter Y, Hahlweg K, et al. Entwicklung und Normierung einer Kurzform des Partnerschaftsfragebogens (PFB-K) an einer repräsentativen deutschen Stichprobe. Z Klin Psychol Psychother. 2012;41:81–9.CrossRef
Metadata
Title
Psychological distress, chronic conditions and quality of life in elderly hematologic cancer patients: study protocol of a prospective study
Authors
Norbert Köhler
Anja Mehnert
Heide Götze
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3662-1

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

Research article

miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene

Research article

Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling

Research article

Disparities of time trends and birth cohort effects on invasive breast cancer incidence in Shanghai and Hong Kong pre- and post-menopausal women

Study protocol

Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)

Research article

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits